Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-105138
Filing Date
2015-03-25
Accepted
2015-03-25 16:59:44
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d891511d10k.htm 10-K 1262997
2 EX-23.1 d891511dex231.htm EX-23.1 1916
3 EX-31.1 d891511dex311.htm EX-31.1 8044
4 EX-31.2 d891511dex312.htm EX-31.2 8059
5 EX-32.1 d891511dex321.htm EX-32.1 3635
6 EX-32.2 d891511dex322.htm EX-32.2 3632
7 GRAPHIC g891511tx_pg009.jpg GRAPHIC 67538
8 GRAPHIC g891511tx_pg010.jpg GRAPHIC 48357
9 GRAPHIC g891511tx_pg012.jpg GRAPHIC 46270
10 GRAPHIC g891511tx_pg013.jpg GRAPHIC 28854
11 GRAPHIC g891511tx_pg016.jpg GRAPHIC 42741
12 GRAPHIC g891511tx_pg018.jpg GRAPHIC 36007
  Complete submission text file 0001193125-15-105138.txt   1661931
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filer) CIK: 0001609351 (see all company filings)

EIN.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36819 | Film No.: 15725247
SIC: 2836 Biological Products, (No Diagnostic Substances)